Canada· CA-DIN-02405776

JAMP NEVIRAPINE

A nevirapine product containing nevirapine, registered in Canada by JAMP PHARMA CORPORATION. The same ATC class is registered in 16 of our 19 countries.

ATC J05AG01

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about nevirapineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Nevirapine is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AG01 (nevirapine), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
9 of them publish a price we can compare per daily dose

Search nevirapine products by name

Nevirapine · ATC J05AG01

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nevirapine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.81 in France to $7.77 in Switzerland — a ×2.0 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Nevirapine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

CH Switzerland$7.77
FR France$3.81

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: NEVIRAPINE
Manufacturer: JAMP PHARMA CORPORATION
Country: Canada (CA)
ATC code: J05AG01
ATC class: Nevirapine
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

316 interactions on record for nevirapine.

Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check nevirapine against other medicines How interaction checks work

Nevirapine · interactions on record

316 records

26 severe
220 moderate
8 minor
49 info

Most severe, free to view

DeflazacortH02AB13severe
BrigatinibL01ED04severe
LorlatinibL01ED05severe
CobimetinibL01EE02severe

13 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nevirapine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nevirapine products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

Austria · Nevirapin Viatris
Belgium · Nevirapine Viatris
Germany · Nevirapin Abdi, Nevirapin Aurobindo
Denmark · Nevirapine Medical Valley, Nevirapine Viatris
Spain · Nevirapina Aurovitas, Nevirapina Kern Pharma
Finland · Nevirapine Viatris
France · Nevirapine Arrow Lab, Nevirapine Cristers
United Kingdom (Northern Ireland) · Nevirapine Accord, Nevirapine Accord Healthcare
Greece · Nevirapine Vocate
Iceland · Viramune
Italy · Nevirapina Aurobindo, Nevirapina Mylan
Liechtenstein · Viramune
Luxembourg · Nevirapine Viatris
Netherlands · Nevirapine Accord, Nevirapine Amarox
Norway · Viramune
Portugal · Nevirapina Accord, Nevirapina Aurovitas
Romania · Nevirapina Accord, Nevirapină Accord
Sweden · Nevirapine Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cdc226ba-b985-499b-b3eb-4165ee7fa34b
GET /v1/drugs/cdc226ba-b985-499b-b3eb-4165ee7fa34b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02405776",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "J05AG01",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "89053",
  "strengths": [
    "200 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "NEVIRAPINE"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about nevirapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console